SKYRIZI
SKYRIZI
Approved
DIN Number
02519283
Drug Class
Human
Market Date
Jun 1, 2022
Company
HC
Abbvie Corporation
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02519283
AIG Number0161390002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
,
Schedule D
A
ATC Code
L04AC18 RIZANKIZUMAB
Product Specifications
Dosage FormSolution
Route of AdministrationSubcutaneous
AHFS Classification84:06.28
Health Canada Classification
ACTIVE INGREDIENTS (1)
RISANKIZUMABActive
Strength: 150 MG / 1 ML
Monograph: RISANKIZUMAB